Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two Monovalent H5N1 Influenza Vaccines Containing 2 Doses of H5N1 Influenza Antigen, in Non-elderly Adult and Elderly Subjects

Novartis Vaccines · 2009
ClinicalTrials.gov · Datasets · License: Public Domain · 2009
Open Source ↗
h5n1
pandemic h5n1 influenza, pandemic influenza, h5n1, adults and elderly, antigen dose, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 844491
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.